STOCK TITAN

Shareholder Harlan Robins files to sell 8,120 ADPT shares (ADPT)

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

A shareholder of ADPT, identified as Harlan Robins, filed a notice to sell 8,120 shares of common stock through Goldman Sachs & Co. LLC, with an aggregate market value of 150,220, on or about 02/03/2026 on the NASD exchange.

The shares to be sold were acquired on 03/06/2023 as compensation in the form of restricted stock units from the issuer. Over the prior three months, the same seller reported multiple open-market sales of common stock, with individual transactions ranging up to 27,212 shares and gross proceeds such as 506,428.93.

Positive

  • None.

Negative

  • None.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does the ADPT Form 144 filing by Harlan Robins disclose?

The filing shows shareholder Harlan Robins plans to sell 8,120 shares of ADPT common stock through Goldman Sachs & Co. LLC. The planned sale has an aggregate market value of 150,220 and is expected to occur around 02/03/2026 on the NASD exchange.

How many ADPT shares did Harlan Robins sell in the past three months?

The notice lists several recent sales of ADPT common stock by Harlan Robins, including transactions of 27,212 shares for 506,428.93 in gross proceeds and other sales of 10,000 shares on multiple dates, plus smaller trades such as 2,395 shares for 44,130.99.

How were the ADPT shares in the planned Form 144 sale originally acquired?

The 8,120 shares of ADPT common stock were acquired on 03/06/2023 as compensation in the form of restricted stock units from the issuer. The filing states these shares were received from the issuer and identifies the nature of payment as compensation.

Which broker is handling the ADPT Form 144 stock sale for Harlan Robins?

The planned sale of 8,120 ADPT common shares will be handled by Goldman Sachs & Co. LLC, located at 200 West Street, New York, NY 10282. The transaction is listed to take place on the NASD securities exchange around 02/03/2026.

What is the outstanding share count referenced in the ADPT Form 144?

The notice indicates that ADPT has 152,665,188 shares of common stock outstanding. This figure provides context for the planned sale of 8,120 shares and the other recent transactions disclosed for shareholder Harlan Robins during the past three months.

What gross proceeds did recent ADPT stock sales by Harlan Robins generate?

Recent ADPT stock sales by Harlan Robins include gross proceeds such as 506,428.93 from selling 27,212 shares, 166,125 from 10,000 shares, and 600,732.85 from 32,273 shares, along with additional smaller trades listed in the filing.
Adaptive Biotechnologies

NASDAQ:ADPT

ADPT Rankings

ADPT Latest News

ADPT Latest SEC Filings

ADPT Stock Data

2.81B
149.19M
2.34%
97.89%
5.54%
Biotechnology
Biological Products, (no Disgnostic Substances)
Link
United States
SEATTLE